查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401914

2030 年神经科学市场预测：按组件、技术最终用户和地区分類的全球分析

Neuroscience Market Forecasts to 2030 - Global Analysis By Components (Instruments, Consumables and Software and Services), By Technology (Whole Brain Imaging, Neuro-Microscopy, Electrophysiology and Other Technologies) End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球神经科学市场规模将达到 456 亿美元，预计到 2030 年将达到 759 亿美元，预测期内复合年增长率为 7.5%。

神经科学是神经系统的跨学科研究，探索其结构、功能、发展以及对行为和认知的影响。它涵盖心理学、生物学和医学等多个领域，深入研究神经元、神经迴路和大脑过程，以了解感知、记忆、情绪和疾病。神经科学旨在破解大脑和神经系统的复杂性，并揭示指导人类思想和行为的基本原则。

根据美国生物技术资讯中心（NCBI）统计，每年有 2,260 万人遭受神经损伤和残疾，其中 1,380 万人需要手术治疗。

脑相关疾病的盛行率不断增加

大脑相关疾病的盛行率迅速上升，成为推动神经科学市场成长的催化剂。阿兹海默症、帕金森氏症和各种精神疾病等疾病的增加增加了对创新诊断工具、治疗方法和疗法的需求。这种激增正在刺激神经科学领域的广泛研究和投资，以揭示大脑的复杂性。此外，先进技术加上对神经机制的深入了解，正在促进有针对性的干预措施的市场开拓并促进市场扩张。

与特定设备相关的成本

神经科学研究所必需的最尖端科技，例如高解析度成像设备、先进的电生理设备和专门的分析工具，通常成本高。这些经济障碍阻止小型研究机构、学术机构甚至一些行业相关人员获得或购买这种关键设备。此外，这些工具的成本集中性质可能会增加整体研发成本，影响预算分配，并从其他重要研究领域转移资源。

神经科学和神经技术的进展

神经科学的不断发展和突破，加上神经技术创新的快速进步，正在为神经科学市场创造巨大的机会。这些进步为突破性发现铺平了道路，加深了我们对大脑复杂性及其功能的理解。先进的影像技术、脑机介面和神经调节设备是增强诊断、治疗和调查方法的突破性技术。这些进步不仅有助于精确绘製神经网络，还可以对神经系统和大脑相关疾病进行更有针对性的干预。

动物实验中的伦理问题

围绕动物测试的伦理问题对神经科学市场构成了重大威胁。社会对在研究中使用动物的福利和伦理影响的日益关注可能会导致对某些实验方法的严格监管、限製或禁止。这限制了调查方法的范围，并限制了理解神经机制的潜在途径。这些限制可能会阻碍科学进步并阻碍治疗方法和疗法新兴市场的开拓，从而限制市场内神经学研究和应用的范围和深度。

COVID-19 的影响：

COVID-19 大流行对神经科学市场产生了重大影响。由于资源转移、研究活动中断以及抗击病毒的重点缩小，许多神经科学计划面临延迟和资金挑战。神经系统疾病的临床试验受到影响，影响了病患招募和资料收集。然而，疫情也刺激了技术创新，凸显了对远端医疗解决方案的需求，并加速了神经科学领域数位健康工具的发展。

预计诊断测试部门在预测期内将是最大的

诊断测试部门预计将引领神经科学市场，因为它在神经诊断的进步中发挥关键作用。这些实验室采用基因检测、生物标记分析等最尖端科技以及 MRI 和 PET 扫描等神经影像技术，可精确识别和了解神经系统疾病。这些实验室专注于早期检测和个人化医疗，在提高诊断准确性、评估预后和推进治疗方面发挥关键作用。此外，全面的测试服务和研究倡议正在推动该领域的扩张。

预测期内，设备产业预期复合年增长率最高

在神经科学市场中，由于对先进和专业设备的需求不断增加，因此预计设备领域的复合年增长率最高。此细分市场包括各种尖端设备，包括神经刺激设备、脑图系统、神经外科设备和成像技术。神经学研究的激增以及对精确诊断和治疗工具的需求推动了成长。此外，仪器技术的不断创新促进了微创手术并提高了精确度，推动了市场扩张。

占有率最大的地区

北美预计将主导市场并占据神经科学市场的最大占有率。这是由于该地区强大的医疗基础设施、广泛的研发活动以及神经系统疾病的高盛行率。主要市场参与企业的存在、对医疗保健的大量投资以及先进技术的实施有助于北美在神经科学市场的领导地位。此外，意识的提高和优惠的报销政策进一步巩固了我们在该地区的市场地位。

复合年增长率最高的地区：

由于医疗基础设施的扩张、研究投资的增加以及神经系统疾病患者数量的快速增加，亚太地区的神经科学市场将显着成长。医疗意识的提高、政府支持医疗进步的努力以及先进技术的采用都促进了这一成长轨迹。此外，专注于解决未满足的医疗需求，再加上亚太地区与国际参与企业之间的合作，正在坚定地定位亚太地区。

免费客製化服务：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球神经科学市场：依组成部分

  • 介绍
  • 装置
  • 消耗品
  • 软体和服务

第六章全球神经科学市场：依技术分类

  • 介绍
  • 全脑影像
    • 脑部功能影像
    • 脑部构造成像
  • 神经显微镜
    • 萤光神经显微镜
      • 共焦萤光显微镜
      • 萤光显微镜
      • TIRF萤光神经显微镜
      • 双光子萤光显微镜
    • 电子神经显微镜
      • 电子断层扫描
      • 扫描式电子神经显微镜
      • 透射穿透式电子显微镜
    • 光学神经显微镜
  • 电生理学
  • 神经生化侦测
  • 神经细胞的操纵
  • 神经功能可视化
  • 神经蛋白质体分析
  • 立体定位手术
    • 长期通路植入
    • 神经活性植入
    • 神经化学
  • 动物行为分析
    • C.优雅相关
    • 果蝇行为相关
    • 非人类灵长类相关
    • 光遗传学致动器
    • 光遗传学感测器
    • 囓齿动物行为相关
  • 其他技术

第七章 全球神经科学市场：依最终用户分类

  • 介绍
  • 医院
  • 诊断实验室
  • 研究和学术机构
  • 其他最终用户

第八章全球神经科学市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Abbott Laboratories
  • ACADIA Pharmaceuticals
  • Alkermes
  • Axsome Therapeutics
  • Biogen
  • Cerevel Therapeutics
  • Cortexyme
  • Eli Lilly and Company
  • Intra-Cellular Therapies
  • Johnson & Johnson
  • Lundbeck
  • Merck & Co.
  • Neurocrine Biosciences
  • Novartis
  • Pfizer
  • Roche
  • Sage Therapeutics
  • Takeda Pharmaceutical Company
  • UCB Pharmaceuticals
  • Voyager Therapeutics
Product Code: SMRC24434

According to Stratistics MRC, the Global Neuroscience Market is accounted for $45.6 billion in 2023 and is expected to reach $75.9 billion by 2030 growing at a CAGR of 7.5% during the forecast period. Neuroscience is the multidisciplinary study of the nervous system, exploring its structure, function, development, and impact on behavior and cognition. It encompasses various fields like psychology, biology, and medicine, delving into neurons, neural circuits, and brain processes to understand perception, memory, emotions, and disorders. Neuroscience aims to decipher the complexities of the brain and nervous system, unraveling fundamental principles guiding human thought and behavior.

According to the National Center for Biotechnology Information (NCBI), each year, 22.6 million people suffer from neurological injuries or disorders, of whom 13.8 million require surgical treatment.

Market Dynamics:

Driver:

Increasing prevalence of brain-related disorders

The burgeoning prevalence of brain-related disorders acts as a catalyst, propelling the growth of the neuroscience market. With conditions like Alzheimer's, Parkinson's, and various mental health disorders on the rise, there's an amplified demand for innovative diagnostic tools, therapies, and treatments. This surge fuels extensive research, encouraging investment in neuroscience to unravel the complexities of the brain. Additionally, advanced technologies, coupled with a deeper understanding of neural mechanisms, drive the development of targeted interventions, fostering the market's expansion.

Restraint:

Expenses associated with specific instruments

Cutting-edge technologies integral to neuroscience research, such as high-resolution imaging devices, advanced electrophysiology equipment, and specialized analytical tools, often come with exorbitant costs. These financial barriers impede smaller research facilities, academic institutions, and even some industry players from accessing or affording these crucial instruments. Moreover, the cost-intensive nature of these instruments escalates the overall expenses in research and development, impacting budget allocations and potentially diverting resources from other essential areas of study.

Opportunity:

Progression in neuroscience and neuro-technological advancements

The continuous evolution and breakthroughs in neuroscience, coupled with the rapid advancement of neuro-technological innovations, present a remarkable opportunity within the neuroscience market. These progressions open avenues for groundbreaking discoveries, fostering a deeper understanding of the complexities of the brain and its functionalities. Advanced imaging techniques, brain-computer interfaces, and neuromodulation devices are among the revolutionary technologies enhancing diagnosis, treatment, and research methodologies. Such advancements not only facilitate precise mapping of neural networks but also enable more targeted interventions for neurological disorders and brain-related conditions.

Threat:

Concerns about ethics in animal experimentation

Ethical apprehensions surrounding animal experimentation pose a significant threat to the neuroscience market. Heightened societal concerns regarding the welfare and ethical implications of using animals in research can lead to stringent regulations, limitations, or even bans on certain experimental practices. This restricts the scope of research methodologies and potential avenues for understanding neural mechanisms. Such limitations can impede scientific progress, hindering the development of treatments and therapies, thereby limiting the scope and depth of neurological research and its applications within the market.

COVID-19 Impact:

The COVID-19 pandemic exerted a considerable influence on the neuroscience market. With diverted resources, disrupted research activities, and redirected focus toward combating the virus, many neuroscience projects faced delays or funding challenges. Clinical trials for neurological disorders were impacted, affecting patient recruitment and data collection. However, the pandemic also spurred innovation, emphasizing the need for telehealth solutions and accelerating digital health tools in neuroscience.

The diagnostic laboratories segment is expected to be the largest during the forecast period

The diagnostic laboratories segment is anticipated to lead the neuroscience market due to its pivotal role in advancing neurological diagnostics. These labs employ cutting-edge technologies, including genetic testing, biomarker analysis, and neuroimaging techniques like MRI and PET scans, enabling precise identification and understanding of neurological disorders. With an emphasis on early detection and personalized medicine, these labs play a crucial role in enhancing diagnostic accuracy, prognostic assessments, and therapeutic advancements. Additionally, their comprehensive testing services and research initiatives are propelling segment expansion.

The instruments segment is expected to have the highest CAGR during the forecast period

The Instruments segment is poised for the highest CAGR in the neuroscience market due to escalating demand for advanced and specialized equipment. This segment encompasses a wide array of cutting-edge devices, including neurostimulation devices, brain mapping systems, neurosurgical instruments, and imaging technologies. The surge in neurological research, coupled with the need for precise diagnostic and therapeutic tools, fuels the growth. Moreover, continuous innovation in instrument technology, fostering minimally invasive procedures and enhanced precision, drives the market's expansion.

Region with largest share:

North America is projected to dominate the market, capturing the largest share of the neuroscience market. This is attributed to the region's robust healthcare infrastructure, extensive research and development activities, and a high prevalence of neurological disorders. The presence of key market players, significant investments in healthcare, and advanced technological adoption contribute to North America's leadership in the neuroscience market. Moreover, increasing awareness and favorable reimbursement policies further solidify the region's position in the market.

Region with highest CAGR:

The Asia-Pacific region is poised for remarkable growth in the neuroscience market owing to expanding healthcare infrastructure, rising investments in research, and a burgeoning patient population with neurological disorders. Increasing awareness, government initiatives supporting healthcare advancements and the adoption of advanced technologies contribute to this growth trajectory. Additionally, a growing focus on addressing unmet medical needs, coupled with collaborations between regional and international players, positions the Asia Pacific region in a robust position.

Key players in the market:

Some of the key players in Neuroscience Market include Abbott Laboratories, ACADIA Pharmaceuticals, Alkermes, Axsome Therapeutics, Biogen, Cerevel Therapeutics, Cortexyme, Eli Lilly and Company, Intra-Cellular Therapies, Johnson & Johnson, Lundbeck, Merck & Co., Neurocrine Biosciences, Novartis, Pfizer, Roche, Sage Therapeutics, Takeda Pharmaceutical Company, UCB Pharmaceuticals and Voyager Therapeutics.

Key Developments:

In November 2023, An international team of scientists has uncovered the vital role of microglia, the immune cells in the brain that acts as its dedicated defense team, in early human brain development. By incorporating microglia into lab-grown brain organoids, scientists were able mimic the complex environment within the developing human brain to understand how microglia influence brain cell growth and development.

In September 2023, H. Lundbeck A/S (Lundbeck) announces new clinical data supporting the efficacy and tolerability of Lu AG09222 for the preventive treatment of migraine at the International Headache Congress (IHC) 2023 in Seoul, Korea. The presentations also include additional data from a proof-of-mechanism study showing that Lu AG09222 can halt PACAP38-triggered vasodilation and headaches.

In September 2023, Abbott announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes. The transaction expands Abbott's presence in diabetes care, building on its world-leading FreeStyle Libre® portfolio of continuous glucose monitoring technology and furthering the company's efforts to develop connected solutions for making diabetes management even more personal and precise.

Components Covered:

  • Instruments
  • Consumables
  • Software and Services

Technologies Covered:

  • Whole Brain Imaging
  • Neuro-Microscopy
  • Electrophysiology
  • Neuro Biochemical Assays
  • Neurocellular Manipulation
  • Neurofunctional Visualization
  • Neuroproteomic Analysis
  • Stereotaxic Surgeries
  • Animal Behavior Analysis
  • Other Technologies

End Users Covered:

  • Hospitals
  • Diagnostic Laboratories
  • Research and Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.6 Research Sources
    • 2.6.1 Primary Research Sources
    • 2.6.2 Secondary Research Sources
    • 2.6.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neuroscience Market, By Component

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Consumables
  • 5.4 Software and Services

6 Global Neuroscience Market, By Technology

  • 6.1 Introduction
  • 6.2 Whole Brain Imaging
    • 6.2.1 Functional Brain Imaging
    • 6.2.2 Structural Brain Imaging
  • 6.3 Neuro-Microscopy
    • 6.3.1 Fluoroscence Neuro-Microscopy
      • 6.3.1.1 Confocal Fluoroscence Microscopy
      • 6.3.1.2 Epifluorescent Fluoroscence Microscopy
      • 6.3.1.3 TIRF Fluoroscence Neuro-Microscopy
      • 6.3.1.4 Two-Photon Fluoroscence Microscopy
    • 6.3.2 Electron Neuro-Microscopy
      • 6.3.2.1 Electron Tomography
      • 6.3.2.2 Scanning electron Neuro-Microscopy
      • 6.3.2.3 Transmission Electron Neuro-Microscopy
    • 6.3.3 Light Neuro-Microscopy
  • 6.4 Electrophysiology
  • 6.5 Neuro Biochemical Assays
  • 6.6 Neurocellular Manipulation
  • 6.7 Neurofunctional Visualization
  • 6.8 Neuroproteomic Analysis
  • 6.9 Stereotaxic Surgeries
    • 6.9.1 Long-Term Access Implants
    • 6.9.2 Neural Activity Implants
    • 6.9.3 Neurochemistry
  • 6.10 Animal Behavior Analysis
    • 6.10.1 C.Elegans Related
    • 6.10.2 Drosophila Behavior Related
    • 6.10.3 Non-Human Primates Related
    • 6.10.4 Optogenetics Actuators
    • 6.10.5 Optogenetics Sensors
    • 6.10.6 Rodent Behavior Related
  • 6.11 Other Technologies

7 Global Neuroscience Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Diagnostic Laboratories
  • 7.4 Research and Academic Institutes
  • 7.5 Other End Users

8 Global Neuroscience Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.6 South America
    • 8.6.1 Argentina
    • 8.6.2 Brazil
    • 8.6.3 Chile
    • 8.6.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 ACADIA Pharmaceuticals
  • 10.3 Alkermes
  • 10.4 Axsome Therapeutics
  • 10.5 Biogen
  • 10.6 Cerevel Therapeutics
  • 10.7 Cortexyme
  • 10.8 Eli Lilly and Company
  • 10.9 Intra-Cellular Therapies
  • 10.10 Johnson & Johnson
  • 10.11 Lundbeck
  • 10.12 Merck & Co.
  • 10.13 Neurocrine Biosciences
  • 10.14 Novartis
  • 10.15 Pfizer
  • 10.16 Roche
  • 10.17 Sage Therapeutics
  • 10.18 Takeda Pharmaceutical Company
  • 10.19 UCB Pharmaceuticals
  • 10.20 Voyager Therapeutics

List of Tables

  • Table 1 Global Neuroscience Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neuroscience Market Outlook, By Component (2021-2030) ($MN)
  • Table 3 Global Neuroscience Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 4 Global Neuroscience Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 5 Global Neuroscience Market Outlook, By Software and Services (2021-2030) ($MN)
  • Table 6 Global Neuroscience Market Outlook, By Technology (2021-2030) ($MN)
  • Table 7 Global Neuroscience Market Outlook, By Whole Brain Imaging (2021-2030) ($MN)
  • Table 8 Global Neuroscience Market Outlook, By Functional Brain Imaging (2021-2030) ($MN)
  • Table 9 Global Neuroscience Market Outlook, By Structural Brain Imaging (2021-2030) ($MN)
  • Table 10 Global Neuroscience Market Outlook, By Neuro-Microscopy (2021-2030) ($MN)
  • Table 11 Global Neuroscience Market Outlook, By Fluoroscence Neuro-Microscopy (2021-2030) ($MN)
  • Table 12 Global Neuroscience Market Outlook, By Confocal Fluoroscence Microscopy (2021-2030) ($MN)
  • Table 13 Global Neuroscience Market Outlook, By Epifluorescent Fluoroscence Microscopy (2021-2030) ($MN)
  • Table 14 Global Neuroscience Market Outlook, By TIRF Fluoroscence Neuro-Microscopy (2021-2030) ($MN)
  • Table 15 Global Neuroscience Market Outlook, By Two-Photon Fluoroscence Microscopy (2021-2030) ($MN)
  • Table 16 Global Neuroscience Market Outlook, By Electron Neuro-Microscopy (2021-2030) ($MN)
  • Table 17 Global Neuroscience Market Outlook, By Electron Tomography (2021-2030) ($MN)
  • Table 18 Global Neuroscience Market Outlook, By Scanning electron Neuro-Microscopy (2021-2030) ($MN)
  • Table 19 Global Neuroscience Market Outlook, By Transmission Electron Neuro-Microscopy (2021-2030) ($MN)
  • Table 20 Global Neuroscience Market Outlook, By Light Neuro-Microscopy (2021-2030) ($MN)
  • Table 21 Global Neuroscience Market Outlook, By Electrophysiology (2021-2030) ($MN)
  • Table 22 Global Neuroscience Market Outlook, By Neuro Biochemical Assays (2021-2030) ($MN)
  • Table 23 Global Neuroscience Market Outlook, By Neurocellular Manipulation (2021-2030) ($MN)
  • Table 24 Global Neuroscience Market Outlook, By Neurofunctional Visualization (2021-2030) ($MN)
  • Table 25 Global Neuroscience Market Outlook, By Neuroproteomic Analysis (2021-2030) ($MN)
  • Table 26 Global Neuroscience Market Outlook, By Stereotaxic Surgeries (2021-2030) ($MN)
  • Table 27 Global Neuroscience Market Outlook, By Long-Term Access Implants (2021-2030) ($MN)
  • Table 28 Global Neuroscience Market Outlook, By Neural Activity Implants (2021-2030) ($MN)
  • Table 29 Global Neuroscience Market Outlook, By Neurochemistry (2021-2030) ($MN)
  • Table 30 Global Neuroscience Market Outlook, By Animal Behavior Analysis (2021-2030) ($MN)
  • Table 31 Global Neuroscience Market Outlook, By C.Elegans Related (2021-2030) ($MN)
  • Table 32 Global Neuroscience Market Outlook, By Drosophila Behavior Related (2021-2030) ($MN)
  • Table 33 Global Neuroscience Market Outlook, By Non-Human Primates Related (2021-2030) ($MN)
  • Table 34 Global Neuroscience Market Outlook, By Optogenetics Actuators (2021-2030) ($MN)
  • Table 35 Global Neuroscience Market Outlook, By Optogenetics Sensors (2021-2030) ($MN)
  • Table 36 Global Neuroscience Market Outlook, By Rodent Behavior Related (2021-2030) ($MN)
  • Table 37 Global Neuroscience Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 38 Global Neuroscience Market Outlook, By End User (2021-2030) ($MN)
  • Table 39 Global Neuroscience Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 40 Global Neuroscience Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 41 Global Neuroscience Market Outlook, By Research and Academic Institutes (2021-2030) ($MN)
  • Table 42 Global Neuroscience Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.